BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 24951810)

  • 1. Rothia bacteremia: a 10-year experience at Mayo Clinic, Rochester, Minnesota.
    Ramanan P; Barreto JN; Osmon DR; Tosh PK
    J Clin Microbiol; 2014 Sep; 52(9):3184-9. PubMed ID: 24951810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morbidity and mortality attributable to Rothia bacteremia in neutropenic and nonneutropenic patients.
    Abidi MZ; Ledeboer N; Banerjee A; Hari P
    Diagn Microbiol Infect Dis; 2016 May; 85(1):116-20. PubMed ID: 26906191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two bacteremia cases associated with Rothia mucilaginosa.
    Kayman T; Akalin T; Ugur H; Bozdogan B; Duyan S
    Clin Lab; 2013; 59(9-10):1167-70. PubMed ID: 24273942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rothia mucilaginosa bacteremia in end-stage renal disease and solid organ transplant: the need for raised awareness.
    Bejjanki H; Koratala A
    Infez Med; 2019 Mar; 27(1):82-84. PubMed ID: 30882384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive Rothia infections in children with acute myeloid leukemia: A report from the Canadian infections in AML research group.
    Wang JY; Brossard J; Cellot S; Dix D; Feusner J; Johnston DL; Lewis V; Mitchell D; Portwine C; Price V; Sung L; Ethier MC; Gillmeister B
    Pediatr Hematol Oncol; 2016 Aug; 33(5):277-281. PubMed ID: 27315594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteremia due to Stomatococcus mucilaginosus in neutropenic patients in the setting of a cancer institute.
    Fanourgiakis P; Georgala A; Vekemans M; Daneau D; Heymans C; Aoun M
    Clin Microbiol Infect; 2003 Oct; 9(10):1068-72. PubMed ID: 14616756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three cases of Rothia dentocariosa bacteraemia: frequency in Denmark and a review.
    Salamon SA; Prag J
    Scand J Infect Dis; 2002; 34(2):153-7. PubMed ID: 11928857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and antimicrobial susceptibility of Bacillus cereus blood stream infections.
    Ikeda M; Yagihara Y; Tatsuno K; Okazaki M; Okugawa S; Moriya K
    Ann Clin Microbiol Antimicrob; 2015 Sep; 14():43. PubMed ID: 26370137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infections due to Stomatococcus mucilaginosus: 10 cases and review.
    Ascher DP; Zbick C; White C; Fischer GW
    Rev Infect Dis; 1991; 13(6):1048-52. PubMed ID: 1775836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bacteremia due to Rothia mucilaginosa after chemotherapy for myeloid malignancies].
    Kohashi S; Mori T; Koda Y; Kikuchi T; Kato J; Shimizu T; Sugita K; Hasegawa N; Murata M; Okamoto S
    Rinsho Ketsueki; 2015 Jun; 56(6):687-91. PubMed ID: 26256880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of coryneform Gram-positive rods from blood identified by MALDI-TOF mass spectrometry and their susceptibility profiles - a retrospective chart review.
    Mushtaq A; Chen DJ; Strand GJ; Dylla BL; Cole NC; Mandrekar J; Patel R
    Diagn Microbiol Infect Dis; 2016 Jul; 85(3):372-376. PubMed ID: 27179368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stomatococcus mucilaginosus septicemia in a patient with acute lymphoblastic leukaemia.
    Treviño M; García-Zabarte A; Quintás A; Varela E; López-Paz JM; Jato A; García-Riestra C; Regueiro BJ
    Eur J Clin Microbiol Infect Dis; 1998 Jul; 17(7):505-7. PubMed ID: 9764554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rothia mucilaginosa bacteremia: A 10-year experience of a pediatric tertiary care cancer center.
    Poyer F; Friesenbichler W; Hutter C; Pichler H; Dworzak M; Peters C; Mann G; Indra A; Attarbaschi A
    Pediatr Blood Cancer; 2019 Jul; 66(7):e27691. PubMed ID: 30825249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bloodstream infections in pediatric patients.
    Babay HA; Twum-Danso K; Kambal AM; Al-Otaibi FE
    Saudi Med J; 2005 Oct; 26(10):1555-61. PubMed ID: 16228055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients.
    Gudiol C; Bodro M; Simonetti A; Tubau F; González-Barca E; Cisnal M; Domingo-Domenech E; Jiménez L; Carratalà J
    Clin Microbiol Infect; 2013 May; 19(5):474-9. PubMed ID: 22524597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stomatococcus mucilaginosus: an emerging pathogen in neutropenic patients.
    McWhinney PH; Kibbler CC; Gillespie SH; Patel S; Morrison D; Hoffbrand AV; Prentice HG
    Clin Infect Dis; 1992 Mar; 14(3):641-6. PubMed ID: 1562654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rothia mucilaginosa bacteraemia in an immunocompetent paediatric patient: a new pathogen to take into account. A case report.
    Luque-Pérez S; Cobos-Carrascosa E; Guarino-Narváez J; Fernández-Puentes V; Eiros JM; Sánchez-Porto A
    Infez Med; 2017 Dec; 25(4):371-373. PubMed ID: 29286019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bacteremia caused by Stomatococcus mucilaginosus in a bone marrow transplantation patient].
    Cobo F; García JA; Jurado M; Alados JC; Miranda C; de la Rosa M
    Enferm Infecc Microbiol Clin; 1998 Mar; 16(3):150-1. PubMed ID: 9611882
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and microbiological features of bacteraemia with Gram-positive anaerobic cocci: a population-based retrospective study.
    Badri M; Nilson B; Ragnarsson S; Senneby E; Rasmussen M
    Clin Microbiol Infect; 2019 Jun; 25(6):760.e1-760.e6. PubMed ID: 30217761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteremia in febrile cancer patients in Uganda.
    Lubwama M; Phipps W; Najjuka CF; Kajumbula H; Ddungu H; Kambugu JB; Bwanga F
    BMC Res Notes; 2019 Jul; 12(1):464. PubMed ID: 31362783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.